Skip to Content

Advantis Corp ADVT

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Advantis Corp is a development stage company. It is pursuing business opportunities to the development of pharmaceutical grade CBD extractions, concentrates and medicines in Nevada, California, and Washington. The company is also establishing partnerships with businesses that develop and sell proprietary consumer products and services. It is developing a product line for the consumer, music, and entertainment sectors.

Contact
1048 Irvine boulevard, Suite 900
Newport Beach, CA, 92660
T +1 949 354-3585
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Sep 30, 2000
Fiscal Year End Dec 31, 2012
Stock Type Cyclical
Employees 12